1. Buprenorphine–naloxone – Suboxone®. Summary of product characteristics;European Medicines Agency,2006
2. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine–naloxone for heroin dependence;Bell;Addiction,2007
3. Buprenorphine+naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection;Prescrire Int,2007
4. Buprénorphine–Subutex®. Résumé des caractéristiques du produit;Afssaps (ANSM),1995
5. Buprenorphine, naloxone. Up to August 2015;Eudravigilance,2015